Victory Capital Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.5M Buy
40,715
+14,254
+54% +$3.79M 0.01% 1064
2025
Q4
$6.52M Sell
26,461
-28,355
-52% -$5.97M ﹤0.01% 1213
2025
Q3
$9.68M Sell
54,816
-25,307
-32% -$3.79M 0.01% 1119
2025
Q2
$11M Buy
80,123
+7,308
+10% +$1.07M 0.01% 1079
2025
Q1
$13.1M Sell
72,815
-8,513
-10% -$1.43M 0.01% 952
2024
Q4
$12.7M Sell
81,328
-16,957
-17% -$3.01M 0.01% 996
2024
Q3
$17.9M Sell
98,285
-45,580
-32% -$8.79M 0.02% 887
2024
Q2
$26.4M Buy
143,865
+9,045
+7% +$1.52M 0.03% 706
2024
Q1
$24M Sell
134,820
-38,059
-22% -$5.29M 0.02% 748
2023
Q4
$21.4M Sell
172,879
-36,608
-17% -$4.06M 0.02% 751
2023
Q3
$24.3M Buy
209,487
+12,448
+6% +$1.52M 0.03% 671
2023
Q2
$23.1M Sell
197,039
-15,091
-7% -$1.54M 0.03% 717
2023
Q1
$17M Sell
212,130
-127,201
-37% -$9.99M 0.02% 845
2022
Q4
$26.9M Buy
339,331
+35,732
+12% +$2.65M 0.03% 668
2022
Q3
$21.2M Buy
303,599
+276,251
+1,010% +$20M 0.02% 784
2022
Q2
$1.79M Buy
+27,348
New +$1.7M ﹤0.01% 1504
2022
Q1
Sell
-2,864
Closed -$200K 2771
2021
Q4
$200K Buy
+2,864
New +$167K ﹤0.01% 2486
2021
Q2
Sell
-2,776
Closed -$214K 2790
2021
Q1
$214K Buy
+2,776
New +$202K ﹤0.01% 2512
2020
Q4
Sell
-524,144
Closed -$22.6M 2564
2020
Q3
$22.6M Buy
524,144
+246,047
+88% +$10.7M 0.03% 739
2020
Q2
$11.5M Buy
278,097
+274,919
+8,651% +$13.2M 0.02% 978
2020
Q1
$138K Buy
3,178
+1,074
+51% +$56.2K ﹤0.01% 2436
2019
Q4
$117K Buy
2,104
+365
+21% +$17.9K ﹤0.01% 2491
2019
Q3
$60K Buy
+1,739
New +$77.7K ﹤0.01% 2603

Other funds holding KRYS